Bausch Health Companies Stock (NYSE: BHC)

Bausch Health Companies

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health Cos

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

News

Markets

Movers

Trading Ideas

COIN

CRCL

GHLD

LZMH

OSCR

SNDK

UPST

GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday

Oil prices rise

Mid Cap

CIVI

NVDA

OKLO

QUBT

Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers.

Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?

KKR investment firm

Opinion

BBIO

BTSG

COOP

DASH

HSIC

KREF

MSGS

NCLH

CSGY

The Smart Money Is Buying These 10 Stocks

Bausch Health Companies Inc. Common Stock

Bausch Health Companies Inc

BillionHappiness

BENCHMARK HLDGS PLC by Benchmark Hldgs PLC

Benchmark Holdings PLC

Press Releases

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health Announces Adoption of Shareholder Rights Plan

Legal

U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

Bausch Health Announces Filing of Supplement to Proxy Statement

Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

Earnings

Bausch Health Announces First Quarter 2025 Results

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

Comments

Bausch Health Companies

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell